Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Kristina Burow

Director at Neumora Therapeutics, Inc. (NMRA); Director at Scholar Rock Holding Corp (SRRK)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-14.8%
vs. S&P 500-16.3%
Beat the market0%
Paper profit on buys−$4.1M
Total bought / sold$5.0M / $164K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 6SEC SRRKScholar Rock Holding Corp Sell Plan 2,105115,605 held (−2%) $53.49 $113K -21.1%
Jul 6SEC SRRKScholar Rock Holding Corp Sell Plan 948114,657 held (−1%) $54.28 $51K -22.3%
Oct 29SEC NMRANeumora Therapeutics, Inc. Buy 1,915,7006,046,907 held (+46%) $2.61 $5.0M -81.8%
  • Sell

    Director Kristina Burow sold $113K of SRRK at $53.49 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Kristina Burow sold $51K of SRRK at $54.28 — pre-scheduled 10b5-1 plan sale.

  • Buy

    Director Kristina Burow bought $5.0M of NMRA at $2.61 — first open-market purchase in our records; raises the stake by 46%.